843 related articles for article (PubMed ID: 19674045)
1. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
2. Development of tolerance to levetiracetam in rats with chronic epilepsy.
van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA
Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
Gibbs JE; Walker MC; Cock HR
Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
[TBL] [Abstract][Full Text] [Related]
5. Effect of antiepileptic drugs on spontaneous seizures in epileptic rats.
Nissinen J; Pitkänen A
Epilepsy Res; 2007 Feb; 73(2):181-91. PubMed ID: 17161937
[TBL] [Abstract][Full Text] [Related]
6. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.
Brandt C; Volk HA; Löscher W
Epilepsia; 2004 Dec; 45(12):1488-97. PubMed ID: 15571506
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
García C; Rubio G
Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
[TBL] [Abstract][Full Text] [Related]
8. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
Mink S; Muroi C; Seule M; Bjeljac M; Keller E
Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
[TBL] [Abstract][Full Text] [Related]
11. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
Bethmann K; Brandt C; Löscher W
Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
[TBL] [Abstract][Full Text] [Related]
12. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.
Taubøll E; Gregoraszczuk EL; Tworzydø A; Wójtowicz AK; Ropstad E
Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877
[TBL] [Abstract][Full Text] [Related]
13. Effects of levetiracetam on hippocampal kindling in Noda epileptic rats.
Ishimaru Y; Chiba S; Serikawa T; Sasa M; Inaba H; Tamura Y; Ishimoto T; Takasaki H; Sakamoto K; Yamaguchi K
Brain Res; 2010 Jan; 1309():104-9. PubMed ID: 19879253
[TBL] [Abstract][Full Text] [Related]
14. Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.
Wojda E; Wlaz A; Patsalos PN; Luszczki JJ
Epilepsy Res; 2009 Oct; 86(2-3):163-74. PubMed ID: 19596559
[TBL] [Abstract][Full Text] [Related]
15. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
[TBL] [Abstract][Full Text] [Related]
16. Anti-glutamatergic effect of riluzole: comparison with valproic acid.
Kim JE; Kim DS; Kwak SE; Choi HC; Song HK; Choi SY; Kwon OS; Kim YI; Kang TC
Neuroscience; 2007 Jun; 147(1):136-45. PubMed ID: 17507170
[TBL] [Abstract][Full Text] [Related]
17. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN
Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135
[TBL] [Abstract][Full Text] [Related]
18. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
19. Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model.
Gibbs JE; Cock HR
Epilepsy Res; 2007 Feb; 73(2):208-12. PubMed ID: 17085017
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
Langer M; Brandt C; Zellinger C; Löscher W
Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
